Vaccination remains one of the most effective public health interventions, yet the long-term success of immunization programs increasingly depends on ethical governance and public trust rather than scientific evidence alone. A recent review published in Vaccine argues that ethical challenges in vaccine research, shifts in immunization policies, and declining confidence in public institutions have become mutually reinforcing threats to global immunization efforts. The authors contend that the greatest risk to vaccination programs is not diminishing vaccine effectiveness, but the erosion of institutional trust that underpins evidence generation, policymaking, and public acceptance.
The review identifies persistent ethical shortcomings in vaccine clinical research, particularly in low- and middle-income countries (LMICs). Although major international ethical frameworks share core principles of participant protection, they vary in their specific provisions regarding informed consent, fair participant selection, protection of vulnerable populations, post-trial access, and placebo use. Analyses of vaccine trials conducted between 2015 and 2023 revealed recurring concerns, including inadequate informed consent procedures, controversial placebo-controlled designs, insufficient commitments to post-trial access, limited community engagement, and inequitable distribution of research benefits. The suspension of a hepatitis B vaccine trial in Guinea-Bissau further demonstrated the ethical dilemmas that arise when study designs conflict with established standards of care. The authors therefore argue that ethical oversight should be guided by internationally accepted principles rather than solely by national policies, particularly in resource-limited settings where existing standards may reflect constrained resources instead of scientific uncertainty.
Beyond research ethics, the review emphasizes that vaccine hesitancy is shaped not by knowledge deficits alone, but also by institutional trust, policy coherence, political polarization, and the perceived legitimacy of decision-making processes. Public confidence is shaped by institutional credibility, political polarization, and the transparency of policy-making processes. Changes in immunization recommendations, especially when presented as reversals or relaxations of previous guidance, may be interpreted as evidence of scientific inconsistency or previously concealed safety concerns. Consequently, vaccine hesitancy should be understood as both an individual behavioral response and a structural outcome of unstable or poorly communicated policy decisions. Maintaining public confidence, therefore requires transparent decision-making, consistent evidence-based recommendations, and effective communication throughout the policy process.
The authors further discuss the global implications of recent changes to the U.S. vaccine recommendation framework. Because U.S. regulatory agencies and advisory committees play a pivotal role in shaping international immunization policies, modifications to recommendation categories may influence public perceptions well beyond the United States. Reclassifying vaccines from universal recommendation to shared clinical decision-making, for example, may unintentionally signal uncertainty regarding vaccine safety or necessity and may weaken confidence in immunization programs beyond the United States. Overall, the review concludes that ethical clinical research, transparent governance, and stable expert oversight are indispensable for sustaining vaccine confidence. Strengthening international ethical standards, preserving evidence-based policymaking, and carefully evaluating the global consequences of influential policy changes will be essential to ensure that scientific advances continue to translate into durable public trust and high vaccination uptake.
Relevant Research:
Sophian A, Sulanjari D, Harumanto A. Global implications of recent changes in U.S. vaccine policy: ethical and trust challenges for immunization programs. Vaccine. 2026;77:128393. doi:10.1016/j.vaccine.2026.128393
https://doi.org/10.1016/j.vaccine.2026.128393
Translating and summarizing: Tianyi Deng
Reviewer: Ziqi Liu
Page Editor: Ruitong Li
